Chemotherapy/Radiation Clinical Trials

1 actively recruiting trial

Also known as: Group 1

Pipeline

Phase 3: 1

Top Sponsors

Hamilton Health Sciences Corporation1

Indications

Liver Disease1
Hepatocellular Carcinoma (HCC)1
Liver Cancer1
Cancer1

Other1 trial

Radiation Therapy Followed by Durvalumab (MEDI4736) and Tremelimumab And Surgery Versus Radiation Therapy Followed by Surgery for Resectable Hepatocellular Carcinoma.

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.